Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "BeST"

798 News Found

Havas Health & You appoints Dan Rubin as President of Havas Health +
People | May 20, 2022

Havas Health & You appoints Dan Rubin as President of Havas Health +

Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum


Driving sustainable, enterprise-wide performance acceleration
Opinion | May 19, 2022

Driving sustainable, enterprise-wide performance acceleration

Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time


Pharmapack Europe awards winners 2022
Packaging | May 19, 2022

Pharmapack Europe awards winners 2022

Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply chain logistics, route of administration, and packaging innovation, as well from the wider industry for patient-centric design and eco-design


Eight Roads announce US $ 250 million healthcare fund for India
News | May 17, 2022

Eight Roads announce US $ 250 million healthcare fund for India

This new fund is amongst the largest for the sector in India


RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools
Drug Approval | May 17, 2022

RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools

Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station


AbbVie and Cugene announce collaboration in autoimmune diseases
News | May 16, 2022

AbbVie and Cugene announce collaboration in autoimmune diseases

AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology


Inmagene receives USFDA IND clearance for a third-generation BTK inhibitor
Biotech | May 16, 2022

Inmagene receives USFDA IND clearance for a third-generation BTK inhibitor

It is developing the drug candidate to potentially treat immunological diseases


KIMS Hospitals sign MoU with Dr Raj Nagarkar to set up a hospital at Nashik
Hospitals | May 15, 2022

KIMS Hospitals sign MoU with Dr Raj Nagarkar to set up a hospital at Nashik

The new hospital is expected to open by March'24


Sarclisa (isatuximab) combination provides unprecedented median progression-free survival
Biotech | May 15, 2022

Sarclisa (isatuximab) combination provides unprecedented median progression-free survival

The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone